epcoritamab

COPENHAGEN, Denmark and NORTH CHICAGO, Ill., July 23, 2026 Genmab and AbbVie have issued a clarification regarding the Phase...

BRONX, New York, July 6, 2026 Montefiore Einstein investigators have published new research demonstrating that expanding the use of...

LONDON, United Kingdom, July 6, 2026 AMO Pharma Limited has announced a significant regulatory milestone for its investigational therapy...

NORTH CHICAGO, Illinois, July 6, 2026 AbbVie has announced that the European Commission (EC) has granted marketing authorization for...

COPENHAGEN, Denmark, July 6, 2026 Genmab A/S announced that the European Commission (EC) has granted marketing authorization for TEPKINLY®...

COPENHAGEN, Denmark, June 29, 2026 Genmab A/S announced positive topline results from the Phase 3 EPCORE DLBCL-4 clinical trial...

COPENHAGEN, Denmark, June 11, 2026 Genmab A/S announced new subgroup analysis results from the pivotal Phase 3 EPCORE FL-1...

NORTH CHICAGO, IL – November 18, 2025 — AbbVie announced that the U.S. Food and Drug Administration (FDA) has...